BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6175228)

  • 21. Effects of proglumide on pancreatic acinar cell function.
    Williams JA; Bailey A; Steigerwalt RW
    Digestion; 1983; 27(4):227-33. PubMed ID: 6197332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temperature dependence of high-affinity CCK receptor binding and CCK internalization in rat pancreatic acini.
    Williams JA; Bailey AC; Roach E
    Am J Physiol; 1988 Apr; 254(4 Pt 1):G513-21. PubMed ID: 3354673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of biologically active radioiodinated cholecystokinin for radioreceptor assay and radioimmunoassay.
    Sankaran H; Deveney CW; Goldfine ID; Williams JA
    J Biol Chem; 1979 Oct; 254(19):9349-51. PubMed ID: 226515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: a comparative study.
    von Schrenck T; Moran TH; Heinz-Erian P; Gardner JD; Jensen RT
    Am J Physiol; 1988 Oct; 255(4 Pt 1):G512-21. PubMed ID: 3177648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization of rebamipide: its cholecystokinin CCK1 receptor binding profile and effects on Ca2+ mobilization and amylase release in rat pancreatic acinar cells.
    Moon SJ; An JM; Kim J; Lee SI; Ahn W; Kim KH; Seo JT
    Eur J Pharmacol; 2004 Nov; 505(1-3):61-6. PubMed ID: 15556137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W; Povoski SP; Bell RH
    J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of interactions between CCK-33 and CCK receptors in isolated dispersed pancreatic acini.
    Hosotani R; Chowdhury P; Doi R; Rayford PL
    J Cell Physiol; 1992 Dec; 153(3):523-7. PubMed ID: 1280279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP; Zhou W; Longnecker DS; Bell RH
    Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The regulatory site of functional GTP binding protein coupled to the high affinity cholecystokinin receptor and phospholipase A2 pathway is on the G beta subunit of Gq protein in pancreatic acini.
    Tsunoda Y; Owyang C
    Biochem Biophys Res Commun; 1995 Jun; 211(2):648-55. PubMed ID: 7540841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct cholecystokinin receptors in brain and pancreas.
    Innis RB; Snyder SH
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6917-21. PubMed ID: 6256771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N alpha-carboxyacyl analogues of CCK with a substituted Gly: interaction with pancreatic and gallbladder CCK receptors.
    von Schrenck T; Müller K; Schulze C; Mirau S; Raedler A; Greten H
    Peptides; 1993; 14(6):1309-15. PubMed ID: 7510882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional cholecystokinin receptors are distinguished kinetically by biotinyl-Tyr-Gly-(Thr28,Nle31)CCK(25-33) in rat pancreatic acini.
    Winand J; Poloczek P; Delporte C; Moroder L; Svoboda M; Christophe J
    Biochim Biophys Acta; 1991 Oct; 1080(2):181-90. PubMed ID: 1718434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS; Liang JP; Owyang C
    Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of gastrin receptors on guinea pig pancreatic acini.
    Yu DH; Noguchi M; Zhou ZC; Villanueva ML; Gardner JD; Jensen RT
    Am J Physiol; 1987 Dec; 253(6 Pt 1):G793-801. PubMed ID: 2447788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini.
    Sarri E; Ramos B; Salido GM; Claro E
    Br J Pharmacol; 2001 Aug; 133(8):1227-34. PubMed ID: 11498507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of stimulated amylase secretion by adrenomedullin in rat pancreatic acini.
    Tsuchida T; Ohnishi H; Tanaka Y; Mine T; Fujita T
    Endocrinology; 1999 Feb; 140(2):865-70. PubMed ID: 9927317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of bombesin receptors on pancreatic acini by cholecystokinin.
    Younes M; Wank SA; Vinayek R; Jensen RT; Gardner JD
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G291-8. PubMed ID: 2465695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleoside diphosphate kinase associated with rat pancreatic membranes regulates CCK receptor affinity.
    Blevins GT; van de Westerlo EM; Williams JA
    Am J Physiol; 1994 Nov; 267(5 Pt 1):G866-74. PubMed ID: 7977749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes in the rat is associated with a reversible postreceptor defect in cholecystokinin action.
    Otsuki M; Goldfine ID; Williams JA
    Gastroenterology; 1984 Oct; 87(4):882-7. PubMed ID: 6205933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.
    Iwamoto Y; Yamamoto R; Kuzuya T
    Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.